{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:21:13Z","timestamp":1785867673539,"version":"3.56.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenetics"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1097\/00008571-199502000-00005","type":"journal-article","created":{"date-parts":[[2006,10,16]],"date-time":"2006-10-16T23:21:42Z","timestamp":1161040902000},"page":"43-49","source":"Crossref","is-referenced-by-count":26,"title":["(S )Oxazepam glucuronidation is inhibited by Ketoprofen and other substrates of UGT2B7"],"prefix":"10.1097","volume":"5","author":[{"given":"M","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B K","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Kalow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Pharmacogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008571-199502000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:18:07Z","timestamp":1785863887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008571-199502000-00005"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1097\/00008571-199502000-00005","relation":{},"ISSN":["0960-314X"],"issn-type":[{"value":"0960-314X","type":"print"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}